ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

NRIX Nurix Therapeutics Inc

15.18
-1.55 (-9.26%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Nurix Therapeutics Inc NRIX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-1.55 -9.26% 15.18 13:00:07
始値 安値 高値 終値 前日終値
16.51 14.862 16.59 15.18 16.73
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1205:06EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/6/1020:00GLOBENurix Therapeutics to Host a Webcast and Conference Call to..
2024/6/0607:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0407:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0405:58EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2920:00GLOBENurix Therapeutics to Participate in the Jefferies Global..
2024/5/2820:00GLOBENurix Therapeutics Appoints Paula G. O’Connor, M.D., as..
2024/5/2120:06EDGAR2Form 8-K - Current report
2024/5/2108:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2108:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2105:00GLOBENurix Therapeutics Announces Board Chair Transition
2024/5/1423:00GLOBENurix Therapeutics Announces Upcoming Oral Presentation of..
2024/5/0720:00GLOBENurix Therapeutics to Participate in RBC Capital Markets..
2024/4/1707:21GLOBENurix Therapeutics Announces Closing of Public Offering and..
2024/4/1212:38GLOBENurix Therapeutics Announces Pricing of Upsized $175.0..
2024/4/1205:00GLOBENurix Therapeutics Announces Proposed Public Offering
2024/4/1020:00GLOBENurix Therapeutics Reports First Quarter Fiscal 2024..
2024/4/1002:15GLOBENurix Therapeutics Reports First Clinical Evidence of CNS..
2024/4/0920:00GLOBENurix Therapeutics Announces Extension of Strategic..
2024/4/0320:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
2024/4/0220:00GLOBENurix Therapeutics Announces Extension of Strategic..
2024/3/2520:00GLOBENurix Therapeutics is Part of a Team of International..
2024/3/2022:40GLOBENurix Presents the Discovery and Chemical Structure of..
2024/3/1120:02EDGAR2Form 8-K - Current report
2024/3/1120:00GLOBENurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
2024/3/0706:00GLOBENurix Therapeutics to Participate in Upcoming Investor..
2024/3/0606:30GLOBENurix Therapeutics Announces Presentations at the American..
2024/2/1709:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:22EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1606:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1606:01EDGAR2Form 8-K - Current report
2024/2/1606:00GLOBENurix Therapeutics Reports Fourth Quarter and Fiscal Year..
2024/2/1521:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1521:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1521:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0206:01GLOBENurix Therapeutics Announces Publication in the Journal..
2024/1/3108:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3108:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3108:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3006:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/1706:48DJNNurix Therapeutics Gets FDA Fast-Track Designation for..
2024/1/1706:01GLOBENurix Therapeutics Receives U.S. FDA Fast Track Designation..
2024/1/0821:03EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBENurix Therapeutics Outlines 2024 Strategic Priorities with..
2024/1/0306:01GLOBENurix Therapeutics to Present at 42nd Annual J.P. Morgan..
2023/12/2207:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..